NASDAQ:IRTC

iRhythm Technologies (IRTC) Stock Forecast, Price & News

$85.50

-1.80 (-2.06%)

(As of 09/22/2023 ET)

Compare

Today's Range: $84.73
▼
$87.99
50-Day Range: $85.50
▼
$116.39
52-Week Range: $84.73
▼
$140.23

Volume: 397,612 shs
Average Volume: 317,320 shs
Market Capitalization: $2.61 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $139.22

iRhythm Technologies MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.78 Rating Score
Upside/Downside: 62.8% Upside
$139.22 Price Target
Short Interest: Bearish
7.62% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.68
Based on 5 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($3.03) to ($2.30) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.24 out of 5 stars

Medical Sector

344th out of 963 stocks

Surgical & Medical Instruments Industry

45th out of 97 stocks

4.4

Analyst's Opinion

Consensus Rating
iRhythm Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on 7 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $139.22, iRhythm Technologies has a forecasted upside of 62.8% from its current price of $85.50.
Amount of Analyst Coverage
iRhythm Technologies has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.0

Short Interest

Percentage of Shares Shorted
7.62% of the outstanding shares of iRhythm Technologies have been sold short.
Short Interest Ratio / Days to Cover
iRhythm Technologies has a short interest ratio ("days to cover") of 6.6.
Change versus previous month
Short interest in iRhythm Technologies has recently decreased by 0.43%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
iRhythm Technologies does not currently pay a dividend.
Dividend Growth
iRhythm Technologies does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for IRTC.

3.7

News and Social Media Coverage

News Sentiment
iRhythm Technologies has a news sentiment score of 1.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for iRhythm Technologies this week, compared to 3 articles on an average week.
Search Interest
Only 4 people have searched for IRTC on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
MarketBeat Follows
6 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, iRhythm Technologies insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.43% of the stock of iRhythm Technologies is held by insiders.

0.6

Earnings and Valuation

Earnings Growth
Earnings for iRhythm Technologies are expected to grow in the coming year, from ($3.03) to ($2.30) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of iRhythm Technologies is -26.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of iRhythm Technologies is -26.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
iRhythm Technologies has a P/B Ratio of 10.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About iRhythm Technologies (NASDAQ:IRTC) Stock

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

IRTC Price History

30 days | 90 days | 365 days | Advanced Chart

IRTC Stock News Headlines

September 24, 2023 | americanbankingnews.com

iRhythm Technologies (NASDAQ:IRTC) Hits New 1-Year Low at $85.01

September 22, 2023 | finance.yahoo.com

Unveiling iRhythm Technologies (IRTC)'s Value: Is It Really Priced Right? A Comprehensive Guide

September 24, 2023 | Chaikin Analytics (Ad)

This Stock Could Go Up 66% or More.

Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. More here.

September 20, 2023 | finance.yahoo.com

iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 33% Below Their Intrinsic Value Estimate

August 29, 2023 | finance.yahoo.com

iRhythm Technologies to Participate in Two Investor Conferences in September

August 29, 2023 | nasdaq.com

Canaccord Genuity Maintains iRhythm Technologies (IRTC) Buy Recommendation

August 9, 2023 | markets.businessinsider.com

Truist Financial Remains a Buy on Irhythm Technologies (IRTC)

August 7, 2023 | markets.businessinsider.com

IRhythm Technologies' Cost Efficiency And Potential Entry Into The Japanese Market Earn Analyst Applaud

September 24, 2023 | Chaikin Analytics (Ad)

This Stock Could Go Up 66% or More.

Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. More here.

August 5, 2023 | markets.businessinsider.com

Strong Zio AT Business Growth Propels iRhythm's Q2 Revenue Surge, Analysts Say Warning Letter Manageable

August 4, 2023 | finance.yahoo.com

Is iRhythm Technologies, Inc. (NASDAQ:IRTC) Potentially Undervalued?

August 3, 2023 | finance.yahoo.com

iRhythm Technologies Announces Second Quarter 2023 Financial Results

August 3, 2023 | finance.yahoo.com

Zio Granted High Medical Needs Designation by the Japanese Ministry of Health, Labour, and Welfare

August 3, 2023 | seekingalpha.com

iRhythm Technologies, Inc. 2023 Q2 - Results - Earnings Call Presentation

July 23, 2023 | markets.businessinsider.com

Truist Financial Sticks to Their Buy Rating for Irhythm Technologies (IRTC)

July 20, 2023 | finance.yahoo.com

iRhythm Technologies to Report Second Quarter 2023 Financial Results on August 3, 2023

July 19, 2023 | msn.com

Baird Initiates Coverage of iRhythm Technologies (IRTC) with Outperform Recommendation

July 19, 2023 | msn.com

iRhythm is a new Outperform at Baird despite FDA warning letter

July 18, 2023 | finance.yahoo.com

NAMCP Independent Third-Party Review Validates Value Proposition of iRhythm Zio XT Service to Health Systems and Payers

July 17, 2023 | markets.businessinsider.com

Irhythm Technologies (IRTC) Gets a Buy from Truist Financial

July 16, 2023 | fool.com

iRhythm Technologies (NASDAQ: IRTC)

July 13, 2023 | msn.com

iRhythm Technologies: Unpacking The FDA Warning Letter

July 11, 2023 | msn.com

Morgan Stanley Reiterates iRhythm Technologies (IRTC) Overweight Recommendation

July 11, 2023 | markets.businessinsider.com

What 11 Analyst Ratings Have To Say About iRhythm Technologies

June 8, 2023 | msn.com

Oppenheimer Maintains iRhythm Technologies (IRTC) Outperform Recommendation

June 7, 2023 | benzinga.com

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of iRhythm Technologies, Inc. - IRT

June 7, 2023 | benzinga.com

President and CEO At This Health Care Company Buys $997K of Stock

See More Headlines

Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

IRTC Company Calendar

Last Earnings: 8/03/2023
Today: 9/24/2023
Next Earnings (Estimated): 11/07/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:IRTC
CUSIP: N/A
CIK: 1388658
Web: www.irhythmtech.com
Phone: (415) 632-5700
Fax: N/A
Employees: 1,793
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $139.22
High Stock Price Forecast: $165.00
Low Stock Price Forecast: $116.00
Forecasted Upside/Downside: +62.8%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.78
Research Coverage: 9 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($3.28)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-116,150,000.00
Net Margins: -21.95%
Pretax Margin: -21.84%
Return on Equity: -41.92%
Return on Assets: -22.28%

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 2.71
Quick Ratio: 2.55

Sales & Book Value

Annual Sales: $410.92 million
Price / Sales: 6.36
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $7.96 per share
Price / Book: 10.74

Miscellaneous

Outstanding Shares: 30,580,000
Free Float: 30,447,000
Market Cap: $2.61 billion
Optionable: Optionable
Beta: 1.33

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Quentin S. Blackford (Age 44)
Pres, CEO & Director
Comp: $2.15M

Mr. Brice Bobzien CPA (Age 44)
Chief Financial Officer
Comp: $685.12k

Dr. Minang P. Turakhia M.D. (Age 49)
M.S., Chief Medical & Scientific Officer and Exec. VP of Product Innovation
Comp: $1M

Mr. Patrick Michael Murphy J.D. (Age 44)
Chief Bus. & Legal Officer
Comp: $1.28M

Mr. Douglas J. Devine (Age 53)
Exec. Advisor
Comp: $800k

Mr. Chad M. Patterson (Age 41)
Chief Commercial Officer
Comp: $771.51k

Mr. Marc Rosenbaum (Age 51)
Sr. VP of Fin. & Chief Accounting Officer

Mr. Mark J. Day Ph.D. (Age 52)
Chief Technology Officer

Mr. Daniel G. Wilson (Age 40)
Exec. VP of Corp. Devel. & Investor Relations

Ms. Sumi Shrishrimal (Age 44)
Exec. VP & Chief Risk Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

IRTC Stock - Frequently Asked Questions

Should I buy or sell iRhythm Technologies stock right now?: 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" IRTC shares.
View IRTC analyst ratings or view top-rated stocks.
What is iRhythm Technologies' stock price forecast for 2023?: 9 brokerages have issued twelve-month price targets for iRhythm Technologies' shares. Their IRTC share price forecasts range from $116.00 to $165.00. On average, they expect the company's share price to reach $139.22 in the next twelve months. This suggests a possible upside of 62.8% from the stock's current price.
View analysts price targets for IRTC or view top-rated stocks among Wall Street analysts.
How have IRTC shares performed in 2023?: iRhythm Technologies' stock was trading at $93.67 at the beginning of the year. Since then, IRTC shares have decreased by 8.7% and is now trading at $85.50.
View the best growth stocks for 2023 here.
When is iRhythm Technologies' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our IRTC earnings forecast.
How were iRhythm Technologies' earnings last quarter?: iRhythm Technologies, Inc. (NASDAQ:IRTC) issued its quarterly earnings results on Thursday, August, 3rd. The company reported ($0.61) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.75) by $0.14. The business earned $124.13 million during the quarter, compared to analysts' expectations of $120.03 million. iRhythm Technologies had a negative trailing twelve-month return on equity of 41.92% and a negative net margin of 21.95%.
What ETFs hold iRhythm Technologies' stock?: ETFs with the largest weight of iRhythm Technologies (NASDAQ:IRTC) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), ROBO Global Healthcare Technology and Innovation ETF (HTEC), SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Robotics & Automation ETF (ROBO), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), BNY Mellon Innovators ETF (BKIV) and Fidelity Disruptive Medicine ETF (FMED).
What guidance has iRhythm Technologies issued on next quarter's earnings?: iRhythm Technologies updated its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $485.00 million-$490.00 million, compared to the consensus revenue estimate of $483.78 million.
What is Kevin M. King's approval rating as iRhythm Technologies' CEO?: 20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of iRhythm Technologies own?: Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA).
When did iRhythm Technologies IPO?: (IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.
What is iRhythm Technologies' stock symbol?: iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."
Who are iRhythm Technologies' major shareholders?: iRhythm Technologies' stock is owned by many different retail and institutional investors. Top institutional shareholders include Sands Capital Management LLC (7.80%), BlackRock Inc. (7.76%), Capital Research Global Investors (7.48%), Artisan Partners Limited Partnership (5.24%), JPMorgan Chase & Co. (4.05%) and Mackenzie Financial Corp (4.01%). Insiders that own company stock include Daniel G Wilson, David A Vort, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Merz Cathleen Noel Bairey, Patrick Michael Murphy and Quentin S Blackford.
View institutional ownership trends.
How do I buy shares of iRhythm Technologies?: Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is iRhythm Technologies' stock price today?: One share of IRTC stock can currently be purchased for approximately $85.50.
How much money does iRhythm Technologies make?: iRhythm Technologies (NASDAQ:IRTC) has a market capitalization of $2.61 billion and generates $410.92 million in revenue each year. The company earns $-116,150,000.00 in net income (profit) each year or ($3.28) on an earnings per share basis.
How many employees does iRhythm Technologies have?: The company employs 1,793 workers across the globe.
How can I contact iRhythm Technologies?: iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The official website for the company is www.irhythmtech.com. The company can be reached via phone at (415) 632-5700 or via email at investors@irhythmtech.com.

This page (NASDAQ:IRTC) was last updated on 9/24/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial